Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued... ...
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usv-in-talks-with-novartis-to-buy-jalra-trademark-for-rs-200-crore/articleshow/72431900.cmsOral anti-diabetic drug maker USV Pvt Ltd on Wednesday announced fresh investment of Rs 400 crore on a new state-of-art formulations plant at Vadodar ...
https://www.thehindubusinessline.com/companies/usv-to-invest-rs-400-cr-for-formulation-plant-at-vadodara/article29510158.ece